The evidence from clinical trials on colchicine and corticosteroids’ effect on COVID-19: a systematic review and meta-analysis
| dc.contributor | Universiti Sains Malaysia | |
| dc.contributor | Universiti Sains Malaysia | |
| dc.contributor.author | Ahmad Naoras Bitar | |
| dc.contributor.author | Syed Azhar Syed Sulaiman | |
| dc.date.accessioned | 2023-05-10T00:52:47Z | |
| dc.date.available | 2023-05-10T00:52:47Z | |
| dc.date.issued | 2022-07-12 | |
| dc.description | With no clear end for the outbreak, identifying the drugs that are effective in COVID-19’s management is of utmost importance to reduce the impact on the general population and the healthcare systems. This is a systematic review and a meta-analysis evaluating the evidence from clinical trials on the effect of colchicine and corticosteroids against COVID-19. In this review, we have systematically searched five databases [(PubMed, Embase, clinicaltrials.gov, ICTRP, CINAHL (EBSCO)]. Cochrane’s data extraction sheet was used to collect the required information, and RevMan-5.4.1 was used to conduct the meta-analysis and to assess the risk of bias. The review was registered in Prospero (CRD42022299718) The total number of included studies was 17, with 18,956 participants; the majority were male 12,001. Out of which, 8772 participants were on colchicine, 569 took methylprednisolone, and 64 patients received prednisolone. The meta-analysis has shown that colchicine had no significant effect on reducing the mortality rate among COVID-19 patients [OR 0.98(95% CI 0.90–1.08), p = .70), I2:1%)], corticosteroids have significantly reduced the mortality rates [OR 0.55 (95% CI 0.33–0.91), p = .02, I2:40]. Colchicine did not reduce the incidence of ICU admissions [OR 0.74 (95% CI 0.39–1.40), p = .35, I2:0%], while steroidal drugs significantly reduced the ICU admissions [OR 0.42 (95% CI 0.23–0.78), p = .005, I2:0%]. Unlike steroidal drugs [OR 0.53 (95% CI 0.30–0.95), p = .03, I2:61%], colchicine failed to reduce the need for mechanical ventilation [OR 0.73 (95% CI 0.48–1.10), p = .13, I2:76%]. Steroidal drugs significantly reduced the duration of hospitalization among COVID-19 patients [OR −0.50 (95% CI −0.79–0.21), p = .0007, I2:36%]. The use of colchicine did not significantly reduce the mortality rate, ICU admissions, and mechanical ventilation among COVID-19 patients. Conversely, corticosteroids significantly reduced the mortality rate, ICU admissions, mechanical ventilation, and hospitalization duration among COVID-19 patients. | |
| dc.identifier.doi | 10.6084/m9.figshare.20291555.v1 | |
| dc.identifier.uri | https://opendata.usm.my/handle/123456789/74637 | |
| dc.publisher | Figshare | |
| dc.rights | CC0 1.0 Universal | * |
| dc.rights.uri | http://creativecommons.org/publicdomain/zero/1.0/ | * |
| dc.title | The evidence from clinical trials on colchicine and corticosteroids’ effect on COVID-19: a systematic review and meta-analysis | |
| dc.type | Dataset |
Files
Original bundle
1 - 1 of 1